# Centerville Clinics Inc

Health Center, PA
Page: https://astrelis.co/providers/health_center/391807  
This twin: https://astrelis.co/providers/health_center/391807.md  
CMS Certification Number (CCN): 391807  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2019 to 2025)

- **Total patients (UDS) (FY2024):** 31,715. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2025):** -14.4%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 36. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 8.1%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2025):** $33.4M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2025):** +7.5%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### Centerville Clinics, Inc., PA

Match to this profile: matched by name (method: name and state).

- FY ending 2025-04-30 (audit year 2025): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2025-04-GSAFAC-0000387080
- FY ending 2024-04-30 (audit year 2024): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2024-04-GSAFAC-0000063222
- FY ending 2023-04-30 (audit year 2023): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2023-04-GSAFAC-0000010585

| Line | FY ending 2025-04-30 | FY ending 2024-04-30 | FY ending 2023-04-30 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | 42,393,606 [derived, p.6] | 37,944,405 [derived, p.6] | 28,327,489 [derived, p.6] |
| patient receivables, net (Statement of financial position) | 4,001,590 [derived, p.6] | 4,318,538 [derived, p.6] | 3,461,447 [derived, p.6] |
| grants and other receivables (Statement of financial position) | 276,444 [derived, p.6] | 660,744 [derived, p.6] | 88,876 [derived, p.6] |
| other current assets (Statement of financial position) | 817,092 [derived, p.6] | 664,213 [derived, p.6] | 1,109,657 [derived, p.6] |
| TOTAL CURRENT ASSETS (Statement of financial position) | 47,488,732 [extracted, p.6] | 43,587,900 [extracted, p.6] | 32,987,469 [extracted, p.6] |
| property and equipment, net (Statement of financial position) | 13,116,086 [derived, p.6] | 11,673,986 [derived, p.6] | 11,304,183 [derived, p.6] |
| other long-term assets (Statement of financial position) | 1,361,014 [derived, p.6] | 4,810,172 [derived, p.6] | 11,417,142 [derived, p.6] |
| TOTAL ASSETS (Statement of financial position) | 61,965,832 [extracted, p.6] | 60,072,058 [extracted, p.6] | 55,708,794 [extracted, p.6] |
| payables and accrued expenses (Statement of financial position) | 1,803,009 [derived, p.7] | 1,939,844 [derived, p.7] | 1,838,713 [derived, p.7] |
| deferred revenue (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | 45,295 [derived, p.7] |
| current debt and leases (Statement of financial position) | 101,592 [derived, p.7] | 108,518 [derived, p.7] | 107,351 [derived, p.7] |
| other current liabilities (Statement of financial position) | 1,426,298 [derived, p.7] | 1,422,132 [derived, p.7] | 1,422,132 [derived, p.7] |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 3,330,899 [extracted, p.7] | 3,470,494 [extracted, p.7] | 3,413,491 [extracted, p.7] |
| long-term debt and leases (Statement of financial position) | 399,433 [derived, p.7] | 492,189 [derived, p.7] | 468,838 [derived, p.7] |
| other long-term liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL LIABILITIES (Statement of financial position) | 3,730,332 [extracted, p.7] | 3,962,683 [extracted, p.7] | 3,882,329 [extracted, p.7] |
| net assets without donor restrictions (Statement of financial position) | 57,982,540 [derived, p.7] | 55,862,089 [derived, p.7] | 51,585,810 [derived, p.7] |
| net assets with donor restrictions (Statement of financial position) | 252,960 [derived, p.7] | 247,286 [derived, p.7] | 240,655 [derived, p.7] |
| TOTAL NET ASSETS (Statement of financial position) | 58,235,500 [extracted, p.7] | 56,109,375 [extracted, p.7] | 51,826,465 [extracted, p.7] |
| patient service revenue, net (Statement of activities) | 32,425,802 [derived, p.8] | 30,464,403 [derived, p.8] | 28,751,503 [derived, p.8] |
| pharmacy and 340B revenue (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| federal grants (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other grants and contracts (Statement of activities) | 6,920,328 [derived, p.8] | 8,234,900 [derived, p.8] | 11,317,718 [derived, p.8] |
| contributions (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other revenue (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 39,346,130 [extracted, p.8] | 38,699,303 [extracted, p.8] | 40,069,221 [extracted, p.8] |
| salaries and benefits (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| supplies and pharmaceuticals (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| purchased and professional services (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| occupancy (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| depreciation and amortization (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| interest (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other expenses (Statement of activities) | 38,237,634 [derived, p.8] | 35,570,861 [derived, p.8] | 33,177,180 [derived, p.8] |
| TOTAL EXPENSES (Statement of activities) | 38,237,634 [extracted, p.8] | 35,570,861 [extracted, p.8] | 33,177,180 [extracted, p.8] |
| OPERATING RESULT (Statement of activities) | 1,108,496 [extracted, p.8] | 3,128,442 [extracted, p.8] | 6,892,041 [extracted, p.8] |
| non-operating and other changes (Statement of activities) | 1,017,629 [derived, p.8] | 1,154,468 [derived, p.8] | 230,380 [derived, p.8] |
| CHANGE IN NET ASSETS (Statement of activities) | 2,126,125 [extracted, p.8] | 4,282,910 [extracted, p.8] | 7,122,421 [extracted, p.8] |
| net assets, beginning (Statement of activities) | 56,109,375 [extracted, p.8] | 51,826,465 [extracted, p.8] | 44,704,044 [extracted, p.8] |
| net assets, end (Statement of activities) | 58,235,500 [extracted, p.8] | 56,109,375 [extracted, p.8] | 51,826,465 [extracted, p.8] |

| Ratio | FY ending 2025-04-30 | FY ending 2024-04-30 | FY ending 2023-04-30 |
|---|---:|---:|---:|
| Days cash on hand | absent [not computed] | absent [not computed] | absent [not computed] |
| Current ratio | 14.26x [plausible] | 12.56x [plausible] | 9.66x [plausible] |
| Operating margin | 2.8% [plausible] | 8.1% [plausible] | 17.2% [plausible] |
| Total margin | 5.4% [plausible] | 11.1% [plausible] | 17.8% [plausible] |
| Patient revenue share | 82.4% [plausible] | 78.7% [plausible] | 71.8% [plausible] |
| Grant dependency | absent [not computed] | absent [not computed] | absent [not computed] |
| Salaries share | absent [not computed] | absent [not computed] | absent [not computed] |
| Days in patient receivables | 45 days [plausible] | 52 days [plausible] | 44 days [plausible] |
| Debt to net assets | 0.01x [plausible] | 0.01x [plausible] | 0.01x [plausible] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Verified). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (Centerville Clinics, Inc.; FAC-11 template snapshot, SRC-FAC-001); the organization match is matched by name.

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "Centerville Clinics Inc", https://astrelis.co/providers/health_center/391807, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.